Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Tomas Mikuckis

Partner, Health & Life Sciences, Oliver Wyman

How New Price Transparency Rules May Impact Payers and Providers

Immediate considerations for the industry.

Principal, Oliver Wyman
Global Head, Health Services, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Practice Leader, Oliver Wyman Actuarial Consulting

Changes are already here, they're real, and we believe they'll scale quickly.

Partner, Health & Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman
Partner, Digital, Oliver Wyman
Senior Consultant, Oliver Wyman

Despite HHS movement mandating that hospitals estimate patients' bills early on, the thing is, healthcare's already pretty shoppable.

Partner, Health & Life Sciences, Oliver Wyman
Principal, Oliver Wyman

Quality, not quantity, will drive the next wave of partnerships and product launches.

Partner, Health & Life Sciences, Oliver Wyman
Engagement Manager, Oliver Wyman
Associate, Health & Life Sciences, Oliver Wyman

27 partnered products were launched last year, with 70 percent joint ventured or co-branded insurance products.

Partner, Health & Life Sciences, Oliver Wyman
Engagement Manager, Oliver Wyman
Associate, Health & Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe

As merger activity heightens, some leverage retail with pharma to meet consumer demand.

Partner, Health & Life Sciences, Oliver Wyman
Principal, Oliver Wyman
Associate, Health & Life Sciences, Oliver Wyman

A detailed look at the 22 new payer-provider partnerships created in Q1 this year.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Engagement Manager, Oliver Wyman
Associate, Health & Life Sciences, Oliver Wyman

Earlier this year, we analyzed payer-provider partnerships. As 2017 comes to a close, we consider the year's steady growth and new twists.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Engagement Manager, Oliver Wyman

A detailed look at payer-provider partnerships. Includes new data from Q1 of this year.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

New analysis reveals the pace (rapid) and shape (more joint ventures) of payer-provider partnerships.

Partner, Health & Life Sciences, Oliver Wyman
Engagement Manager, Oliver Wyman

Insights in your inbox

Subscribe